New imaging agent targets LRRC15 to sharpen cancer diagnosis
NCT ID NCT07651020
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special SPECT imaging agent that seeks out a protein called LRRC15, found on many aggressive cancers like pancreatic, breast, lung, and brain tumors. The goal is to see if this scan can help doctors diagnose and stage these cancers more accurately. Healthy volunteers and people with suspected or confirmed LRRC15-positive cancers will receive the imaging agent and undergo a SPECT/CT scan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LRRC15-targeted SPECT radiotracer
What this could lead to
If successful, this imaging method could improve cancer diagnosis and staging, helping doctors choose better treatments.
What could go wrong
This is a very early, small study with only one participant, so results may not apply broadly. The imaging agent's safety and accuracy are still being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wuhan Union Hospital, China
Wuhan, Hubei, 430030, China